<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">Traditional herbal products and drugs of indigenous origin have an ancient history of curing several chronic and infective diseases. A range of various plant metabolites are shown to impede virus replication without affecting the host physiology or with limited side-effects (
 <xref rid="b0175" ref-type="bibr">Martin and Ernst, 2003</xref>, 
 <xref rid="b0115" ref-type="bibr">Hussain et al., 2017</xref>). In addition to their ability to interfere directly with viral replication, these natural products may also modulate the host immune response against infection (
 <xref rid="b0145" ref-type="bibr">Kurokawa et al., 2010</xref>). In line with this, several natural or plant-derived compounds belonging to different chemical classes have been reported to have potential anti-HBV activities (
 <xref rid="b0050" ref-type="bibr">Chen et al., 1995</xref>, 
 <xref rid="b0040" ref-type="bibr">Chang et al., 2005</xref>, 
 <xref rid="b0255" ref-type="bibr">Wang, 2000</xref>; Huang et al., 2008; 
 <xref rid="b0080" ref-type="bibr">Chou et al., 2012</xref>, 
 <xref rid="b0210" ref-type="bibr">Qiu and Chen, 2013</xref>, 
 <xref rid="b0265" ref-type="bibr">Wu, 2016</xref>, 
 <xref rid="b0205" ref-type="bibr">Parvez et al., 2016</xref>). Compared to interferons or lamivudine treatment, some plant products are reported with similar or even better efficacy (
 <xref rid="b0045" ref-type="bibr">Chen and Zhu, 2013</xref>, 
 <xref rid="b0020" ref-type="bibr">Arbab et al., 2017</xref>, 
 <xref rid="b0275" ref-type="bibr">Zhang et al., 2017</xref>). Interestingly therefore, approximately 80% of the CHB patients in China rely on traditional herbal medicines.
</p>
